Applied DNA Sciences Dirección
Dirección controles de criterios 4/4
El CEO de Applied DNA Sciences' es James Hayward , nombrado en Apr 2006, tiene una permanencia de 18.58 años. compensación anual total es $468.00K, compuesta por 96.2% salario y 3.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.78% de las acciones de la empresa, por valor de $33.55K. La antigüedad media del equipo directivo y de la junta directiva es de 9.2 años y 8.2 años, respectivamente.
Información clave
James Hayward
Chief Executive Officer (CEO)
US$468.0k
Compensación total
| Porcentaje del salario del CEO | 96.2% |
| Permanencia del CEO | 18.1yrs |
| Participación del CEO | 0.8% |
| Permanencia media de la dirección | 9.3yrs |
| Promedio de permanencia en la Junta Directiva | 8.3yrs |
Actualizaciones recientes de la dirección
Recent updates
The Market Doesn't Like What It Sees From Applied DNA Sciences, Inc.'s (NASDAQ:APDN) Revenues Yet As Shares Tumble 26%
Dec 20
Is Applied DNA Sciences (NASDAQ:APDN) In A Good Position To Invest In Growth?
Jan 01Applied DNA climbs 51% after winning large purchase order
Oct 10Applied DNA stock rises 12% on launching monkeypox testing service in New York
Sep 06Applied DNA adds 17% as company seeks approval for monkeypox test in New York
Aug 19Upgrade: Analysts Just Made A Notable Increase To Their Applied DNA Sciences, Inc. (NASDAQ:APDN) Forecasts
Aug 17Applied DNA Sciences gains as it secures ~$3.6M proceeds from warrant exercise
Aug 09Applied DNA stock soars 73% on starting validation of PCR-based monkeypox test
Aug 02Applied DNA announces positive data from veterinary vaccine trial to treat COVID-19
Jul 25News Flash: Analysts Just Made A Notable Upgrade To Their Applied DNA Sciences, Inc. (NASDAQ:APDN) Forecasts
May 18Is Applied DNA Sciences (NASDAQ:APDN) In A Good Position To Deliver On Growth Plans?
Sep 17Applied DNA's LinearDNA COVID-19 vaccine booster yields 5-fold increase in neutralizing antibody in felines
May 06Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$7m |
| Sep 30 2023 | US$468k | US$450k | -US$10m |
| Jun 30 2023 | n/a | n/a | -US$7m |
| Mar 31 2023 | n/a | n/a | -US$5m |
| Dec 31 2022 | n/a | n/a | -US$7m |
| Sep 30 2022 | US$2m | US$450k | -US$8m |
| Jun 30 2022 | n/a | n/a | -US$12m |
| Mar 31 2022 | n/a | n/a | -US$15m |
| Dec 31 2021 | n/a | n/a | -US$14m |
| Sep 30 2021 | US$1m | US$400k | -US$14m |
| Jun 30 2021 | n/a | n/a | -US$14m |
| Mar 31 2021 | n/a | n/a | -US$14m |
| Dec 31 2020 | n/a | n/a | -US$15m |
| Sep 30 2020 | US$451k | US$133k | -US$13m |
| Jun 30 2020 | n/a | n/a | -US$10m |
| Mar 31 2020 | n/a | n/a | -US$9m |
| Dec 31 2019 | n/a | n/a | -US$8m |
| Sep 30 2019 | US$375k | US$233k | -US$9m |
| Jun 30 2019 | n/a | n/a | -US$11m |
| Mar 31 2019 | n/a | n/a | -US$12m |
| Dec 31 2018 | n/a | n/a | -US$12m |
| Sep 30 2018 | US$481k | US$250k | -US$12m |
| Jun 30 2018 | n/a | n/a | -US$11m |
| Mar 31 2018 | n/a | n/a | -US$11m |
| Dec 31 2017 | n/a | n/a | -US$12m |
| Sep 30 2017 | US$546k | US$282k | -US$13m |
Compensación vs. Mercado: La compensación total de James($USD468.00K) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD674.46K).
Compensación vs. Ingresos: La compensación de James ha sido consistente con los resultados de la empresa en el último año.
CEO
James Hayward (69 yo)
18.1yrs
Permanencia
US$468,000
Compensación
Dr. James A. Hayward, Ph D., Sc D., has been Chief Executive Officer and Chairman of Applied DNA Sciences, Inc. (Formerly Known as Prohealth Medical Tech, Inc) since March 17, 2006 and since June 12, 2007...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman | 18.1yrs | US$468.00k | 0.78% $ 27.4k | |
| Chief Financial Officer | 9.3yrs | US$501.00k | 0.00046% $ 16.2 | |
| COO, Chief Information Officer & Secretary | 10.9yrs | US$542.75k | 0.059% $ 2.1k | |
| Chief Legal Officer & Executive Director of Business Development | 3.1yrs | US$501.00k | 0% $ 0 | |
| Executive Director of Investor Relations & Corporate Communications | 3.8yrs | sin datos | sin datos |
9.3yrs
Permanencia media
56yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de APDN es experimentado (9.2 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman | 18.7yrs | US$468.00k | 0.78% $ 27.4k | |
| Chairman of Strategic Advisory Board & Independent Director | 8.3yrs | US$152.50k | 0.011% $ 396.7 | |
| Independent Director | 18.2yrs | US$162.50k | 0.0092% $ 323.0 | |
| Member of Strategic Advisory Board | 7.3yrs | sin datos | sin datos | |
| Independent Director | 9.4yrs | US$155.00k | 0.0032% $ 114.4 | |
| Independent Director | 18.2yrs | US$151.25k | 0.00046% $ 16.2 | |
| Member of Strategic Advisory Board | 7.6yrs | sin datos | sin datos | |
| Member of Strategic Advisory Board | 8.3yrs | sin datos | sin datos | |
| Independent Director | 6.9yrs | US$153.75k | 0.0045% $ 159.5 | |
| Member of Strategic Advisory Board | 5.3yrs | sin datos | sin datos |
8.3yrs
Permanencia media
72yo
Promedio de edad
Junta con experiencia: La junta directiva de APDN se considera experimentada (8.2 años de antigüedad promedio).